Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orthofix MedicalOFIX -0.32%58 Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus rates OFIX with a GF Score™ of 58/100 and a GF Value™ of $13.94 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 439 Medical Devices & Instruments companies, Orthofix Medical ranks worse than 94.53% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Orthofix Medical (NAS:OFIX) Capex-to-Operating-Cash-Flow Explanation
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Orthofix Medical Capex-to-Operating-Cash-Flow Related Terms
Orthofix Medical Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Orthofix Medical's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orthofix Medical Capex-to-Operating-Cash-Flow Chart
OFIX vs MOBI, PACB, CATX: Capex-to-Operating-Cash-Flow Comparison
For the Medical Devices subindustry, Orthofix Medical's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orthofix Medical Capex-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Orthofix Medical's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.00 mean?
Orthofix Medical (OFIX) has a Capex-to-Operating-Cash-Flow of 0.00 as of Jun. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Orthofix Medical and its competitors. Over the past decade, Orthofix Medical's Capex-to-Operating-Cash-Flow has ranged from 0.23 to 2.71. According to the industry distribution chart, Orthofix Medical ranks #415 out of 439 companies in the Medical Devices & Instruments industry, placing it in the top 94.5%.
Is Orthofix Medical's Capex-to-Operating-Cash-Flow too high?
Orthofix Medical's current Capex-to-Operating-Cash-Flow is 0.00. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 2.71. Based on the distribution chart, Orthofix Medical ranks #415 out of 439 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Orthofix Medical has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Orthofix Medical's Capex-to-Operating-Cash-Flow compare to MOBI and PACB?
According to the Medical Devices & Instruments industry distribution chart, Orthofix Medical ranks #415 out of 439 companies for Capex-to-Operating-Cash-Flow. This places Orthofix Medical in the lower half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.41. Historically, Orthofix Medical's own Capex-to-Operating-Cash-Flow has ranged from 0.23 to 2.71 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Medical Devices & Instruments company?
The median Capex-to-Operating-Cash-Flow among Medical Devices & Instruments companies is 0.41, based on 439 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Orthofix Medical and its competitors. For the Medical Devices & Instruments industry, the median Capex-to-Operating-Cash-Flow is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orthofix Medical's current Capex-to-Operating-Cash-Flow is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orthofix Medical stock overvalued right now?
Based on GuruFocus' analysis, Orthofix Medical (OFIX) is currently considered Possible Value Trap. The stock's GF Value™ is $13.94, compared to a current price of $9.29 — trading 33.4% below its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.00. Orthofix Medical's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Orthofix Medical (OFIX), the current Capex-to-Operating-Cash-Flow is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orthofix Medical (OFIX) Overvalued in 2026?
Based on GuruFocus' analysis, Orthofix Medical stock appears to be undervalued.
The current stock price of $9.29 is trading 33.4% below its estimated GF Value™ of $13.94.
GuruFocus considers Orthofix Medical to be Possible Value Trap.
Key valuation signals for OFIX:
Capex-to-Operating-Cash-Flow: 0.00
GF Value™: $13.94 vs. price of $9.29 (33.4% below fair value)
No single metric tells the full story. See the OFIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
58GF Score
Get the complete analysis for OFIX
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OFIX has been successfully added to your 
